Zobrazeno 1 - 10
of 33
pro vyhledávání: '"H. Lozet"'
Publikováno v:
European Journal of Epidemiology. 13:87-93
This study examines the predicting factors for absenteeism in depressed patients. Using a ‘cross-sectional’ design, we observed 345 patients diagnosed with major depressive disorders as assessed by the Diagnostic and Statistical Manual for Mental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d06dbffb5869de6a6c7ece22d7e1b3c6
https://doi.org/10.1023/a:1007397913193
https://doi.org/10.1023/a:1007397913193
Publikováno v:
Journal of Antimicrobial Chemotherapy. 37:151-161
The economic impacts in terms of cost and effectiveness (speed of resolution of symptoms) of 3- and 5-day courses of azithromycin and a 10-day course of roxithromycin were compared in a randomized, open study in patients with symptoms suggestive of b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9e0744ba7005f9cdac897346a9e2529
https://doi.org/10.1093/jac/37.suppl_c.151
https://doi.org/10.1093/jac/37.suppl_c.151
Publikováno v:
Journal of Psychosomatic Research. 38:151-160
The aim of this study was to assess the relative impact of co-mobidity and of symptom severity on the costs of caring for patients with generalized anxiety disorders (GAD). One thousand and forty-two patients with GAD according to DSM III-R were obse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e470fe60a1d42500be04a8b2c2e00f9d
https://doi.org/10.1016/0022-3999(94)90145-7
https://doi.org/10.1016/0022-3999(94)90145-7
Publikováno v:
European Journal of Neurology. 4:387-389
Data from 112 patients with severe, refractory, partial epilepsy, who were treated with adjunct vigabatrin, were used to compare the cost-of-care for patients who responded to the therapy and those who did not. For patients who responded to vigabatri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3a0924e58faa6f912c17dcb14803d8b
https://doi.org/10.1111/j.1468-1331.1997.tb00366.x
https://doi.org/10.1111/j.1468-1331.1997.tb00366.x
Publikováno v:
International clinical psychopharmacology. 11(1)
Quality of life is one of the effectiveness measures used to assess the impact of medical interventions. This paper describes results of a study on quality of life of depressed patients treated with fluoxetine or tricyclic antidepressants (TCAs) such
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17862d4a36c1d6acb42dd0f4f32a0888
https://pubmed.ncbi.nlm.nih.gov/8732313
https://pubmed.ncbi.nlm.nih.gov/8732313
Publikováno v:
Alzheimer Disease ISBN: 9781461581512
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fe167af1f5967d28ae19a98a99dc4eb
https://doi.org/10.1007/978-1-4615-8149-9_78
https://doi.org/10.1007/978-1-4615-8149-9_78
Publikováno v:
Therapie. 48(2)
The goal of our study was to explore the impact of various antidepressant drugs on the relative risk of work loss in depressed patients. 1,852 depressed patients (DSM III-R) were observed using a "cross-sectional" design. Patients were included into
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::695fde2710e2ef4661bb0dbcc426062b
https://pubmed.ncbi.nlm.nih.gov/8351692
https://pubmed.ncbi.nlm.nih.gov/8351692
Publikováno v:
L'Encephale. 18(3)
The aim of this study is to assess the economic impact of neuroleptic strategies in the long-term treatment of schizophrenic patients. In this respect a new neuroleptic strategy (amisulpride) was compared to a reference drug (haloperidol) using a cos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::91ec832af2d1398f526d530b796750a1
https://pubmed.ncbi.nlm.nih.gov/1363727
https://pubmed.ncbi.nlm.nih.gov/1363727
Autor:
H. Lozet, J. M. Chignon, P. Martin, G. Darcourt, P. Barthouil, J. Tignol, Henry Dufour, J. Ades, E. Souetre
Publikováno v:
Clinical Neuropharmacology. 15:156B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6757de9eb6192a019958afe2755ec947
https://doi.org/10.1097/00002826-199202001-00300
https://doi.org/10.1097/00002826-199202001-00300
Autor:
P. Martin, J. M. Chignon, P. Barthouil, J. Ades, J. Tignol, G. Darcourt, Henry Dufour, E. Souetre, D. Gerard, H. Lozet
Publikováno v:
Clinical Neuropharmacology. 15:492B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::733772caa1e4f0469e54323c752e9bd7
https://doi.org/10.1097/00002826-199202001-00957
https://doi.org/10.1097/00002826-199202001-00957